Neffy (epinephrine nasal spray) 1mg is approved for the emergency treatment of type 1 allergic reactions, including ...

Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS ...

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial. Glenmark’s epinephrine injection USP, 10 mg/10 mL (1 mg/mL) ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic reactions in patients who weigh between 15 and 30 kilograms, the company said on ...

1Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial is only approved for the indication(s) listed in Glenmark's approved label. 2Market includes brand and all available ...

July 29, 2004) has further highlighted ongoing serious problems with epinephrine labeling and ... between dose concentrations (such as 1:1,000 or 1 mg/mL and 1:10,000 or 0.1 mg/mL), and (2 ...